Antimicrobial Resistance and Multilocus Sequence Typing of Vancomycin-Resistant Enterococcus faecium Isolated from the Chungcheong Area
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Enterococcus faecium has emerged as an important nosocomial pathogen worldwide, and this trend has been associated with the dissemination of a genetic lineage designated clonal complex 17 (CC17). In the present study, characterization of the glycopeptide resistance mechanism, genetic relatedness, and pathogenicity in isolates of vancomycin-resistant E. faecium in the Chungcheong area were investigated. Methods: A total of 37 consecutive, non-duplicate, vancomycin-resistant E. faecium were isolated at three university hospitals in the Chungcheong area. The mechanism of glycopeptide resistance and pathogenicity factors were studied using PCR, and the genetic relatedness was determined via multilocus sequence type and esp repeat profile analysis. Additionally, the quinolone resistance-determining regions of parC and gyrA were sequenced to identify mutations involved in ciprofloxacin resistance. Results: Two genotypes of VRE were confirmed: VanAphenotype vanA genotype VRE (25 isolates) and VanB-phenotype vanA genotype VRE (12 isolates). MLST analysis revealed five sequence types. A significant result was that ST414 and CNS4 (4-1-1-1-1-1-1) were considered as belonging to CC17. The esp and hyl genes were found in 100% and 86.4% of the isolates, respectively. A total of 37 isolates showed genetic mutations in parC and gyrA. Conclusion: All isolated strains in the present study belonged to one of the CC17 genotypes including ST414 and CNS4 (4-1-1-1-1-1-1), which were not previously detected in Korea. The combination of MLST and the esp gene repeat profiles can be useful for genetic characterization of VREF isolates with regard to the evolutionary process and epidemiology of the clones.
Abstract
Background: Enterococcus faecium has emerged as an important nosocomial pathogen worldwide, and this trend has been associated with the dissemination of a genetic lineage designated clonal complex 17 (CC17). In the present study, characterization of the glycopeptide resistance mechanism, genetic relatedness, and pathogenicity in isolates of vancomycin-resistant E. faecium in the Chungcheong area were investigated. Methods: A total of 37 consecutive, non-duplicate, vancomycin-resistant E. faecium were isolated at three university hospitals in the Chungcheong area. The mechanism of glycopeptide resistance and pathogenicity factors were studied using PCR, and the genetic relatedness was determined via multilocus sequence type and esp repeat profile analysis. Additionally, the quinolone resistance-determining regions of parC and gyrA were sequenced to identify mutations involved in ciprofloxacin resistance. Results: Two genotypes of VRE were confirmed: VanAphenotype vanA genotype VRE (25 isolates) and VanB-phenotype vanA genotype VRE (12 isolates). MLST analysis revealed five sequence types. A significant result was that ST414 and CNS4 (4-1-1-1-1-1-1) were considered as belonging to CC17. The esp and hyl genes were found in 100% and 86.4% of the isolates, respectively. A total of 37 isolates showed genetic mutations in parC and gyrA. Conclusion: All isolated strains in the present study belonged to one of the CC17 genotypes including ST414 and CNS4 (4-1-1-1-1-1-1), which were not previously detected in Korea. The combination of MLST and the esp gene repeat profiles can be useful for genetic characterization of VREF isolates with regard to the evolutionary process and epidemiology of the clones.
참고문헌 (27)
- Joon Young Song, "Prevalence and Molecular Epidemiology of Vancomycin-Resistant Enterococci (VRE) Strains Isolated from Animals and Humans in Korea", The Korean Journal of Internal Medicine, 20(1), pp.55~62 (2005), 대한내과학회
- Choi YH, "Molecular relationship of vanA glycopeptide resistance gene in enterococci from hospitalized patients and poultry in Korea", Korean J Infect Dis, 33, pp.383~391 (2001)
- 최원석, "Vancomycin 내성 장구균에 의한 세균뇨의 역학과 임상적 중요성", Infection and Chemotherapy, 38(5), pp.242~249 (2006), 대한감염학회
- Willems RJ, "Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex", Emerg Infect Dis, 11, pp.821~828 (2005)
- Top J, "Emergence of clonal complex 17 Enterococcus faecium in the Netherlands", J Clin Microbiol, 46, pp.214~219 (2008)
- 이경원, "Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Korea", JOURNAL OF CLINICAL MICROBIOLOGY, 43(5), pp.2303~2306
- Lee WG, "Molecular characterization of Enterococcus faecium isolated from hospitalized patients in Korea", Lett Appl Microbiol, 43, pp.274~279 (2006)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. M100-S18 (M2)", Clinical and Laboratory Standards Institute, ~ (2008)
- Ribeiro T, "Vancomycinsusceptible dairy and clinical enterococcal isolates carry vanA and vanB genes", Int J Food Microbiol, 113, pp.289~295 (2007)
- Homan WL, "Multilocus sequence typing scheme for Enterococcus faecium", J Clin Microbiol, 40, pp.1963~1971 (2002)
- Khan MA, "Analysis of VanA vancomycin-resistant Enterococcus faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 and two new Tn1546 lineage types", J Antimicrob Chemother, 62, pp.279~283 (2008)
- Leavis H, "A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity", J Bacteriol, 186, pp.672~682 (2004)
- Leavis HL, "High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium", J Clin Microbiol, 44, pp.1059~1064 (2006)
- Eom JS, "Emergence of vanA genotype vancomycin-resistant enterococci with low or moderate levels of teicoplanin resistance in Korea", J Clin Microbiol, 42, pp.1785~1786 (2004)
- Arthur M, "Genetics and mechanisms of glycopeptide resistance in enterococci", Antimicrob Agents Chemother, 37, pp.1563~1571 (1993)
- Reynolds PE, "Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-Dserine", Antimicrob Agents Chemother, 49, pp.21~25 (2005)
- Lee WG, "Reduction in glycopeptide resistance in vancomycin-resistant enterococci as a result of vanA cluster rearrangements", Antimicrob Agents Chemother, 48, pp.1379~1381 (2004)
- 오재영, "임상가검물에서 분리된 Vancomycin 내성 Enterococcus faecium의 항균제 내성과 Multilocus Sequence Type 분석", Journal of Bacteriology and Virology, 38(1), pp.19~28 (2008), 대한미생물학회
- "Enterococcus faecium MLST database"[URL]
- Peta M, "Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit", Clin Microbiol Infect, 12, pp.163~169 (2006)
- Shankar V, "Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein", Infect Immun, 67, pp.193~200 (1999)
- Toledo-Arana A, "The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation", Appl Environ Microbiol, 67, pp.4538~4545 (2001)
- Oancea C, "Conjugative transfer of the virulence gene, esp, among isolates of Enterococcus faecium and Enterococcus faecalis", J Antimicrob Chemother, 54, pp.232~235 (2004)
- Freitas AR, "Global spread of the hyl (Efm) colonization-virulence gene in megaplasmids of the Enterococcus faecium CC17 polyclonal subcluster", Antimicrob Agents Chemother, 54, pp.2660~2665 (2010)
- Panesso D, "Molecular epidemiology of vancomycin-resistant Enterococcus faecium: a prospective, multicenter study in South American hospitals", J Clin Microbiol, 48, pp.1562~1569 (2010)
- Rice LB, "A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin", J Infect Dis, 187, pp.508~512 (2003)
- Camargo IL, "Multilocus sequence typing and analysis of putative virulence factors in vancomycin-resistant and vancomycin-sensitive Enterococcus faecium isolates from Brazil", Clin Microbiol Infect, 12, pp.1123~1130 (2006)